DRUG

deucravacitinib

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for deucravacitinib

Inflammatory bowel disease 1

Mediator Outcome Score Tier Lit. status Trial
TYK2 colitis 0.208 Mid reproduces known completed

Clinical trials

100 registered trials for deucravacitinib

Source: ClinicalTrials.gov

← All drugs